Actively Recruiting
A Longitudinal Study of Severe and Enduring Eating Disorders
Led by Uppsala University Hospital · Updated on 2024-12-31
800
Participants Needed
1
Research Sites
1265 weeks
Total Duration
On this page
Sponsors
U
Uppsala University Hospital
Lead Sponsor
F
Forte
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this observational longitudinal study is to investigate characteristics and factors associated with the development of Severe and Enduring Eating Disorders (SEED). In this project, the researchers will follow two prospective cohorts of patients with eating disorders (ED), one adolescent (ages 14-17) and one adult (ages 18+), in terms of change in and impact of clinical, psychological, and biological risk factors. Data will be collected at baseline, after treatment, two years after baseline, and thereafter five, 10 and 20 years after baseline. Participants will be asked to undergo a physical examination, leave blood samples, be interviewed, and fill in questionnaires. If the participants are minors, their care takers will also fill in the questionnaires. The study aims to explore how clinical, psychological, and biological risk factors-including comorbidity, personality characteristics, difficulties with emotion regulation (ER), cognitive inflexibility, loneliness, severe ED symptoms, and inflammatory activation-contribute to a chronic course of the disorder.
CONDITIONS
Official Title
A Longitudinal Study of Severe and Enduring Eating Disorders
Who Can Participate
Eligibility Criteria
You may qualify if you...
Inclusion criteria:
- found to meet the criteria for an eating disorder
- being in need of treatment
- having provided written informed consent (for minors, this includes consent from all caregivers and the minors themselves).
Exclusion criteria:
- Eating disorders symptoms in need of emergency care
- High risk for suicide
- An inability to respond to the questionnaires due to e.g., lack of knowledge in Swedish.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Uppsala University Hospital
Uppsala, Sweden, 75185
Actively Recruiting
Research Team
M
Martina Isaksson, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here